Trials / Conditions / Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis (EoE)

24 registered clinical trials studyying Eosinophilic Esophagitis (EoE) — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis NCT07234825	Kate Farms Inc	N/A
Not Yet Recruiting	Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis. NCT07358234	Mayo Clinic	EARLY_Phase 1
Recruiting	A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic E NCT07112378	Regeneron Pharmaceuticals	Phase 3
Recruiting	Surface EMG Testing on Swallowing in EoE Patients NCT07156357	Mayo Clinic	—
Not Yet Recruiting	Trans-Cervical and Trans-abdominal Ultrasound for Monitoring Esophageal Thickness in Eosinophilic Esophagitis NCT07057986	Sheba Medical Center	N/A
Completed	BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY) NCT07102329	IRCCS San Raffaele	—
Recruiting	Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier NCT07012928	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	—
Enrolling By Invitation	Tolerability of Baked Dairy Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger NCT06756581	Shaare Zedek Medical Center	N/A
Recruiting	A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As NCT06693531	Regeneron Pharmaceuticals	—
Recruiting	Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esop NCT06665971	University of California, San Diego	Phase 4
Active Not Recruiting	A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis NCT06598462	Uniquity One (UNI)	Phase 2
Recruiting	Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy NCT06389994	Children's Hospital of Philadelphia	—
Completed	SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects NCT05485779	AQILION AB	Phase 1
Completed	Prostaglandin and Cannabinoid Receptors in EoE NCT04626609	Medical University of Graz	—
Completed	Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esoph NCT04394351	Regeneron Pharmaceuticals	Phase 3
Completed	Eating With Eosinophilic Esophagitis (EoE) NCT03581838	Mayo Clinic	—
Terminated	Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophil NCT03245840	Shire	Phase 3
Completed	SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study NCT02778867	Children's Hospital Medical Center, Cincinnati	Phase 2 / Phase 3
Completed	An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspe NCT02736409	Shire	Phase 3
Completed	A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determ NCT02605837	Shire	Phase 3
Completed	Mucosal Impedance in Pediatric Population NCT02320981	Vanderbilt University Medical Center	—
Terminated	Bethanechol for Eosinophilic Esophagitis NCT02058537	University of Iowa	Phase 2
Completed	OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an NCT01642212	Shire	Phase 2
Completed	Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis NCT00762073	Shire	Phase 2